Hillstream BioPharma

/Hillstream BioPharma

IPO

Hillstream BioPharma

Biotechnology

Hillstream BioPharma is a pre-clinical biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death (“IMCD”) for treatment resistant cancers.

Symbol

HILS

Price Range
$5.00 - $6.00

Final Shares
3,000,000

Anticipated Date
January 12, 2022

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is no longer available

To view the prospectus for Hillstream BioPharma IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange